-
动态
2025年4月30日，由郑州市医学会与北京积水潭医院郑州医院（郑州市中心医院）联合主办的“第二届LVA手术治疗阿尔茨海默症国际论坛”在郑州隆重召开。本次大会汇聚中、德、美、澳等多国权威专家，聚力攻坚全球共同面临的难题：阿尔茨海默病（AD）。来自显微外科、淋巴外科、神经外科、神经内科及老年医学等多个领域的知名学者齐聚一堂。论坛采用线下参会与线上双语同传直播的形式，现场参会人数达260余人，线上观看突破102万人次，引发广泛关注，河南电视台、郑州电视台等多家媒体专题报道。阿尔茨海默病，这种常被称作“记忆的幽灵”的疾病，正悄然影响着无数家庭。据统计，我国目前阿尔茨海默病患者已超过千万，预计到2050年将达到4000万人。失去记忆的不仅是患者，更是整个家庭共同面对的心碎与无力。而此次论坛的召开，正是为了照亮那条艰难却充满希望的路。会议特别邀请到德国哥廷根大学医疗中心Jens Wiltfang教授、“脑类淋巴系统”发现者、美国华盛顿大学医学院Jonathan Kipnis教授以及等多位国内外顶尖专家。他们的到来不仅带来了国际前沿视角，也让更多医务人员和公众了解到：LVA手术为阿尔茨海默病治疗打开了新的可能。在过去一年里，北京积水潭医院郑州医院已经完成此类手术280余台，术后有效率达73%，许多患者重新拥有了与家人沟通的能力，重拾了生活的信心。北京积水潭医院郑州医院党委书记马西文在开幕致辞中表示，医院自2016年设立记忆门诊以来，逐步构建起“筛查－诊疗－康复－随访”的全流程服务体系。在国家、省市政策的引导下，在国际专家的支持与合作下，郑州正用行动写下“健康老龄化”的答案。这不只是一场学术论坛，更是一场凝聚全球智慧、守护人类记忆的接力。当医生、科学家、政策制定者和公众携手同行，我们终将有一天，不再惧怕“遗忘”。郑州，这座中原城市，正在用实际行动参与全球阿尔茨海默症防治格局的重塑。北京积水潭医院郑州医院团队，正让“郑州经验”逐步走向世界。
On April 30, 2025, The 2nd International Forum on LVA Surgery for Alzheimer's Disease", jointly organized by the Zhengzhou Medical Association and Beijing Jishuitan Hospital Zhengzhou Hospital (Zhengzhou Central Hospital), was grandly held in Zhengzhou. The forum brought together leading experts from China, Germany, the United States, Australia to address the global challenge of Alzheimer’s Disease (AD).Renowned experts from microsurgery, lymphatic surgery, neurosurgery, neurology, and geriatrics gathered for this event. The forum adopted a hybrid format, combining on-site participation with bilingual live streaming. The forum attracted over 260 onsite attendees and drew more than 1.02 million online views, garnering widespread attention from the professionals, the public and major media outlets, including Henan TV and Zhengzhou TV.Alzheimer’s disease, often referred to as the "thief of memory," is quietly devastating millions of families. Statistics show that China currently has over 10 million AD patients, and it is expected to reach 40 million by 2050. The loss of memory is not just the patient’s burden, it is also a heartbreaking ordeal for entire families.This forum aimed to illuminate a challenging yet hopeful path forward.Distinguished guests included Prof. Jens Wiltfang from the University Medical Center Göttingen and Prof. Jonathan Kipnis from the Washington University School of Medicine in St. Louis, the discoverer of the " Brain Meningeal Lymphatic System." Their participation provided cutting-edge international perspectives and highlighted the potential of LVA surgery in treating AD. Over the past year, Beijing Jishuitan Hospital Zhengzhou Hospital has performed over 280 such procedures, achieving an overall efficacy rate of 73%. Many patients have regained the ability to communicate with loved ones and reclaimed their confidence and quality of life.MA Xiwen, Secretary of the Party Committee of Beijing Jishuitan Hospital Zhengzhou Hospital, stated in her opening speech that since the establishment of the Memory Clinic in 2016, the hospital has gradually built a full-process service system of "screening-diagnosis-rehabilitation-follow-up". Guided by national, provincial, and municipal policies, and supported by international cooperation, Zhengzhou is answering the call for "healthy aging" with actions. This was not just an academic forum—it was a global relay of wisdom to safeguard the memories of humankind. When clinicians, scientists, policymakers, and the public work together, one day we'll no longer fear "forgetting". Zhengzhou, a central Chinese city, is participating in reshaping the global landscape of Alzheimer's disease prevention and treatment with practical actions. The team at Beijing Jishuitan Hospital Zhengzhou Hospital is bringing the "Zhengzhou Experience" to the world.
